Dengue - Day 7, Platelets 7,000, Hct 48%, BP Normal, No Danger Signs

What This Picture Means

1. Day 7 of Illness - Critical Context

• Febrile phase: Days 1-3 (fever, myalgia)
• Critical phase: Days 3-6 (defervescence, plasma leakage, platelet nadir)
• Recovery phase: Days 7 onward (reabsorption of leaked fluid, rising platelets)

2. Platelets 7,000/µL - Severely Low But Contextually Reassuring

• Platelet count alone does NOT determine the need for platelet transfusion in dengue
• WHO guidelines and all major dengue management protocols state: platelets are transfused based on bleeding, NOT on the count alone
• Spontaneous severe bleeding risk becomes significant typically below 10,000-20,000, but dengue thrombocytopenia is generally consumptive/immune-mediated - the bone marrow suppression is transient and self-limiting
• On Day 7, platelets have likely hit nadir and will begin rising over the next 24-48 hours (the PMC trend data shows mean platelet counts beginning to climb from Day 8 onward)
• No platelet transfusion is indicated if there is no active significant bleeding

3. Hematocrit 48% - Mild Elevation, Watch Carefully

• Hct 48% is borderline elevated - it may represent mild hemoconcentration from plasma leakage (a hallmark of DHF/dengue with plasma leakage)
• A >20% rise from baseline Hct is a WHO criterion for plasma leakage (e.g., baseline 38% → >45.6% would suggest leakage)
• However, Hct can also appear mildly elevated due to pre-existing factors
• On Day 7, if this is the same or slightly lower than the Day 5-6 reading, it actually signals plasma reabsorption beginning - the Hct should start falling in recovery. If it is still rising, that is concerning
• Watch for: if Hct drops suddenly and bleeding appears, this may indicate hemodilution or hemorrhage

4. BP Normal, No Danger Signs - Most Reassuring Finding

• Severe abdominal pain or tenderness
• Persistent vomiting
• Rapid breathing / respiratory distress
• Bleeding from gums, nose, in vomit or stool
• Fatigue, restlessness, or altered consciousness
• Sudden drop in temperature (defervescence) with shock signs
• Liver enlargement >2 cm

Clinical Bottom Line

Recommended Action

1. Admit and monitor - do not discharge despite stable BP; platelet count is critically low
2. Serial monitoring every 6-12 hours: Hct, platelet count, BP, pulse, urine output
3. Oral hydration if tolerated; IV fluids only if oral intake is inadequate
4. No platelet transfusion unless active significant/severe bleeding occurs
5. No NSAIDs, no aspirin - paracetamol only for fever
6. Watch for danger signs - particularly bleeding and hemodynamic instability
7. Platelet count is expected to begin rising within 24-48 hours on Day 7-8

Key message: Platelet 7k sounds alarming, but with normal BP, no danger signs, and being on Day 7, the patient is clinically stable and likely entering the recovery phase. Management is watchful waiting with close monitoring, not emergency intervention.